Amoxicillin

Edina Avdic, Pharm.D., Paul A. Pham, Pharm.D.
Pediatric Dosing Author: Alice Jenh Hsu, PharmD, BCPS, AQ-ID
Amoxicillin is a topic covered in the Johns Hopkins ABX Guide.

To view the entire topic, please or purchase a subscription.

Pediatrics Central™ is an all-in-one application that puts valuable medical information, via your mobile device or the web, in the hands of clinicians treating infants, children, and adolescents. Explore these free sample topics:

Pediatrics Central

-- The first section of this topic is shown below --

INDICATIONS

FDA

Treatment of infections due to susceptible (β-lactamase-negative) strains causing following syndromes:

  • Infections of the ear, nose, and throat – due to Streptococcus spp. (α- and β-hemolytic strains), S. pneumoniae, Staphylococcus spp., or H. influenzae
  • Infections of the genitourinary tract – due to E. coli, P. mirabilis, or E. faecalis. Note: empiric use is not recommended by IDSA due to higher rates of resistance to E. coli and poor efficacy[3].
  • Infections of the skin and skin structure – due to Streptococcus spp. (α- and β-hemolytic strains), Staphylococcus spp., or E. coli
  • Infections of the lower respiratory tract – due to Streptococcus spp. (α- and β-hemolytic strains), S. pneumoniae, Staphylococcus spp., or H. influenzae
  • Gonorrhea, acute uncomplicated (ano-genital and urethral infections) – due to N. gonorrhoeae (males and females). Note: amoxicillin is not recommended by CDC for the treatment of gonorrhea due to high rates of resistance.
  • H. pylori eradication to reduce the risk of duodenal ulcer recurrence in combination with other agents.

Amoxicillin ER tablet (Mmoxtag™) is indicated for the treatment of tonsillitis and/or pharyngitis secondary to Streptococcus pyogenes in adults and pediatric patients ≥12 y/o

NON-FDA APPROVED USES

-- To view the remaining sections of this topic, please or purchase a subscription --

Last updated: March 7, 2019